ClinicalTrials.gg
Not yet recruitingNCT07473869CRTAppUpdated Mar 16, 2026

Smartphone Application for Automated Measurement of Capillary Refill Time (CRT)

An observational study in Capillary Refill Time and Peripheral Tissue Perfusion, sponsored by Assistance Publique - Hôpitaux de Paris. Not yet recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-03-16.

Sponsored by Assistance Publique - Hôpitaux de Paris · Observational

From the registry’s dates

  • Primary completion was expected by Jun 2026, 5 months ago, but the record still lists the study as not yet recruiting.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
60
Ages
18 Years and older
Sex
All
01

Study summary

This prospective, monocenter observational study aims to validate a smartphone application (CRTApp) that automatically measures capillary refill time (CRT) from a short video of a standardized finger compression. Sixty adult intensive care unit (ICU) patients will undergo a CRT measurement recorded with a professional Android smartphone. Clinical CRT will be determined from the video by three blinded observers (reference = median of the three measurements). The application will analyze the same video locally to provide an automated CRT measurement. Agreement between automated and clinical reference CRT will be assessed, and predefined subgroup analyses will explore performance across skin tone, ambient lighting, smartphone characteristics, and severity of peripheral hypoperfusion.

Read the detailed description

Capillary refill time (CRT) is a bedside indicator of peripheral perfusion, but visual assessment is prone to inter-observer variability. In this study, CRT is measured using a standardized method (10-second finger compression with a glass slide). A video of the fingertip is captured without audio; framing is strictly limited to the fingers. Files are pseudonymized at acquisition. Videos are transferred via USB to an AP-HP workstation and stored on an AP-HP server; no cloud or messaging is used, and videos are deleted from the smartphone after import. Automated CRT is computed locally from the video by CRTApp without network transmission and without retaining the video. Statistical analyses will include intraclass correlation coefficient and Bland-Altman analysis for agreement. Secondary analyses will evaluate agreement stratified by skin tone (Monk scale / ITA), ambient lighting (lux), smartphone characteristics, and severity of peripheral hypoperfusion.

02

Conditions studied

  • Capillary Refill Time
  • Peripheral Tissue Perfusion

Keywords

  • Observer Variation
  • Reproducibility of Results
  • Capillary Refill Time
  • Peripheral Tissue Perfusion
  • Hemodynamic Monitoring
  • Shock
  • Critical Illness
  • Intensive Care Units
  • Smartphone Application
  • Automated Measurement
  • Digital Health
  • Clinical Assessment
03

In context

Shock

487 studies on the registry are indexed under Shock; 107 are open to participants now.

This study's planned enrollment of 60 is below the median of 100 across 247 observational studies indexed under Shock.

Browse Shock studies →

Lead sponsor

Assistance Publique - Hôpitaux de Paris is the lead sponsor of 3,592 studies on the registry; 1,033 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adults (≥18 years) admitted to the medical intensive care unit at Hôpital de Bicêtre (AP-HP) for whom a standardized capillary refill time measurement can be performed.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age ≥ 18 years
  • Adult patients hospitalized in an intensive care unit
  • Clinical indication for capillary refill time assessment (hemodynamic monitoring, suspected peripheral hypoperfusion, or therapeutic evaluation)
  • No objection from the patient or legal representative

Exclusion criteria

Exclusion Criteria:

  • Skin lesions at the measurement site
  • Known severe peripheral vascular disease
  • Finger amputation
  • Presence of distinctive skin marks on fingers (tattoos, significant scars, or prominent moles) that may interfere with measurement or increase the risk of patient re-identification
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
60 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Agreement Between Automated and Clinical Capillary Refill Time Measurement

    Agreement between capillary refill time measured by the smartphone application and the clinical reference measurement performed by expert clinicians using the standardized method (10-second glass slide compression). Agreement is assessed using the intraclass correlation coefficient between the automated measurement and the median of three blinded observers.

    Time frame: At inclusion (single assessment)

Secondary outcomes

  1. Inter-Observer Variability of Clinical Capillary Refill Time Measurement

    At inclusion (single assessment)

    Time frame: Inter-observer variability of clinically measured capillary refill time assessed by three independent observers, expressed as the coefficient of variation.

  2. Agreement Stratified by Skin Tone

    Intraclass correlation coefficient between automated and clinical capillary refill time measurements stratified according to skin tone using the Monk Skin Tone Scale.

    Time frame: At inclusion (single assessment)

  3. Agreement Stratified by Ambient Lighting Conditions

    At inclusion (single assessment)

    Time frame: Intraclass correlation coefficient between automated and clinical capillary refill time measurements stratified according to ambient light intensity measured in lux.

  4. Agreement Stratified by Smartphone Model Characteristics

    At inclusion (single assessment)

    Time frame: Intraclass correlation coefficient between automated and clinical capillary refill time measurements stratified by smartphone type (iOS or Android) and camera resolution.

  5. Agreement Stratified by Severity of Peripheral Hypoperfusion

    At inclusion (single assessment)

    Time frame: Intraclass correlation coefficient between automated and clinical capillary refill time measurements stratified by clinical capillary refill time (< 3 seconds versus ≥ 3 seconds).

07

Study locations

1 site
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jun 2026; primary completion for Jun 2026, 0 months later.

Of 120 non-industry observational studies under Shock, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 52. This study's planned 0 months is below that.

Counting every sponsor, half of 127 studies reached it within 26 months; a quarter within 12 and three quarters within 52.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 11, 2026
First posted
Mar 16, 2026
StartEst.
Jun 1, 2026
Primary completionEst.
Jun 1, 2026
CompletionEst.
Jun 1, 2027
Last update
Mar 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 16, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07473869
Responsible party
Sponsor
First posted
Mar 16, 2026
Start date
Jun 1, 2026 (estimated)
Primary completion
Jun 1, 2026 (estimated)
Completion
Jun 1, 2027 (estimated)
Last update
Mar 16, 2026

Study contacts

Xavier MONNET, PhD
Contact
xavier.monnet@aphp.fr
45213547 ext. +33
Gwénolé ABGRALL
Contact
gwenoleabgrall@gmail.com

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion